From AI design to experimental validation: The next frontier in antibody discovery
This article is sponsored by GenScript. Integration of artificial intelligence (AI) into antibody drug discovery is occurring in phases, as AI models mature, and developers seek to compress discovery and development timelines. While increasingly iterative and feedback-driven approaches to AI-driven antibody discovery have made the process more efficient,… Read More